Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06824727 · ClinicalTrials.gov registry record
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT06824727: Completed study, sponsored by Case Comprehensive Cancer Center.
NCT06824727 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06824727 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.
Interventions
- OTHER Baseline cell blood counts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2025-08-21 |
What the finished NCT06824727 record still lists
NCT06824727 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Baseline cell blood counts is the first listed.
NCT06824727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06824727 about?
NCT06824727 is a clinical study titled "Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia". The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.
What is the current status of trial NCT06824727?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2025-01-06. Estimated completion is 2025-08-21.
What interventions are being tested in trial NCT06824727?
The interventions under investigation include: Baseline cell blood counts (OTHER).
Who is sponsoring clinical trial NCT06824727?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI